enGene Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Saint Laurent
SEC filing record 1 source field available
Fiscal year end
31 October
enGene Therapeutics Inc. has filed 258 SEC EDGAR filings since 14 Jun 2023

SEC filing history

Showing 201-225 of 258 matching filings.

Per page
25
Current page
9
8-K File 001-41854

CURRENT REPORT

Filing date
21 Dec 2023
Reporting date
18 Dec 2023
Next action
Verify source filing
3

3 filing

Filing date
19 Dec 2023
Reporting date
18 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41854

CURRENT REPORT

Filing date
13 Dec 2023
Reporting date
13 Dec 2023
Next action
Verify source filing
UPLOAD File 333-275700

UPLOAD filing

Filing date
08 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Dec 2023
Reporting date
30 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Dec 2023
Reporting date
30 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
29 Nov 2023
Reporting date
27 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41854

CURRENT REPORT

Filing date
29 Nov 2023
Reporting date
27 Nov 2023
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

THE SCHEDULE 13G

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

SC 13G

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
13 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94211

SC 13D

Filing date
13 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41854

CURRENT REPORT

Filing date
09 Nov 2023
Reporting date
08 Nov 2023
Next action
Verify source filing
SC 13D File 005-94211

SC 13D

Filing date
08 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
07 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

SCHEDULE 13G

Filing date
07 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Nov 2023
Reporting date
30 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Nov 2023
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .